1. 符立梧 中国 中山大学 Therapeutic strategies for EGFR-mutated non-small cell lung cancer patients with osimertinib resista..
2. 孙士勇 美国 Emory University Therapeutic potential of the novel Bcl-2/Bcl-X-L dual inhibitor, APG1252, alone or in combination ag..
3. 孙士勇 美国 Emory University Targeting apoptosis to manage acquired resistance to third generation EGFR inhibitors
4. Frank,Schneider 德国 RWTH Aachen University Multiplexed protein profiling reveals spatial subcellular signaling networks
5. Suresh S,Ramalingam 美国 Emory University Multiplexed protein profiling reveals spatial subcellular signaling networks
6. 孙士勇 美国 Emory University Multiplexed protein profiling reveals spatial subcellular signaling networks
7. Frank,Schneider 德国 RWTH Aachen University MERTK activation drives osimertinib resistance in EGFR-mutant non small cell lung cancer
8. Suresh S,Ramalingam 美国 Emory University MERTK activation drives osimertinib resistance in EGFR-mutant non small cell lung cancer
9. Taofeek K,Owonikoko 美国 Emory University MERTK activation drives osimertinib resistance in EGFR-mutant non small cell lung cancer
10. H. Shelton,Earp 美国 University of Iowa MERTK activation drives osimertinib resistance in EGFR-mutant non small cell lung cancer
11. Hiroyuki,Mano 日本 University of Tokyo Preclinical assessment of combination therapy of EGFR tyrosine kinase inhibitors in a highly heterog..
12. Sun, Jong-Mu 韩国 Sungkyunkwan University ERK inhibitor ASN007 effectively overcomes acquired resistance to EGFR inhibitor in non-small cell l..
13. Keunchil,Park 韩国 Sungkyunkwan University ERK inhibitor ASN007 effectively overcomes acquired resistance to EGFR inhibitor in non-small cell l..
14. Myung-Ju,Ahn 韩国 Sungkyunkwan University ERK inhibitor ASN007 effectively overcomes acquired resistance to EGFR inhibitor in non-small cell l..
15. Suresh S,Ramalingam 美国 Emory University Inhibition of MEK5/ERK5 signaling overcomes acquired resistance to the third generation EGFR inhibit..
16. 孙士勇 美国 Emory University Inhibition of MEK5/ERK5 signaling overcomes acquired resistance to the third generation EGFR inhibit..
17. Taofeek K,Owonikoko 美国 Emory University Targeting c-Myc to Overcome Acquired Resistance of EGFR Mutant NSCLC Cells to the Third-Generation E..
18. Suresh S,Ramalingam 美国 Emory University Targeting c-Myc to Overcome Acquired Resistance of EGFR Mutant NSCLC Cells to the Third-Generation E..
19. 孙士勇 美国 Emory University Targeting c-Myc to Overcome Acquired Resistance of EGFR Mutant NSCLC Cells to the Third-Generation E..
20. Prabhash, Kumar 印度 Tata Memorial Hospital Weekly osimertinib dosing prevents EGFR mutant tumor cells destined to home mouse lungs